ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,246.68
0.48%
Dow Jones
39,558.11
0.32%
US Dollar vs MXN
16.8462
-0.01%
Brent Oil
82.745
0.24%
Bitcoin
61,875.31
0.53%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Heart Test Laboratories Inc (HSCS)

  7. Heart Test Laboratories Inc (HSCS) Noticias

HSCS Heart Test Laboratories Inc

0.08
0.0094 (13.31%)
14 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Heart Test Laboratories Inc HSCS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0094 13.31% 0.08 18:46:54
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0735 0.0721 0.082 0.0791 0.0706
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202408:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
02/4/202415:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/3/202408:00GLOBEHeartSciences Announces Podium Presentation at World..
14/3/202415:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/3/202408:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/3/202408:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
05/3/202415:55EDGAR2Form S-1 - General form for registration of securities under..
26/2/202416:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202408:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
15/2/202415:30EDGAR2Form 8-K - Current report
12/2/202408:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/2/202408:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
31/1/202408:00EDGAR2Form 8-K - Current report
25/1/202407:59EDGAR2Form 8-K - Current report
18/1/202407:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202407:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202407:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
18/1/202406:55EDGAR2Form 8-K - Current report
03/1/202415:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
14/12/202315:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
14/12/202315:07EDGAR2Form 8-K - Current report
14/12/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/12/202316:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202307:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/12/202316:14EDGAR2Form DEF 14A - Other definitive proxy statements
07/12/202316:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
06/12/202308:21EDGAR2Form 8-K - Current report
05/12/202307:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
28/11/202316:26EDGAR2Form PRE 14A - Other preliminary proxy statements
27/11/202315:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202307:30EDGAR2Form 8-K - Current report
21/11/202307:30EDGAR2Form 8-K - Current report
20/11/202307:00GLOBEHeartSciences Announces Closing of License Agreements with..
17/11/202315:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202315:26EDGAR2Form 8-K - Current report
13/11/202307:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202308:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
13/10/202320:36EDGAR2Form S-1/A - General form for registration of securities..
04/10/202316:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202307:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/9/202307:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
22/9/202315:16EDGAR2Form 8-K - Current report
21/9/202307:00EDGAR2Form 8-K - Current report
21/9/202307:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
18/9/202305:09EDGAR2Form S-3 - Registration statement under Securities Act of..
14/9/202315:24EDGAR2Form 8-K - Current report
14/9/202315:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
14/9/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/9/202315:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
11/9/202315:15GLOBEHeartSciences Named Electrocardiography Advancement..

Su Consulta Reciente

NASDAQ
HSCS
Heart Test Laboratories
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados